Evidence map›Paper›PMID 22341651›Full record

ArticleDNA repair2012

The human gastric cancer-associated DNA polymerase β variant D160N is a mutator that induces cellular transformation.

Katherine A Donigan, Suzanne E Hile, Kristin A Eckert, Joann B Sweasy

Open access · greenAbstract read
In one paragraph

Article in DNA repair, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 25 citations in OpenAlex.

  1. Harnessing DNA polymerase beta defect enhances synthetic lethality and treatment response in gastric cancer cells: implication for immunotherapy.Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques · 2025
    Review
  2. Article
  3. Review
  4. The Role of Natural Polymorphic Variants of DNA Polymerase β in DNA Repair.International journal of molecular sciences · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Base Excision Repair Variants in Cancer.Methods in enzymology · 2017
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Cellular roles of DNA polymerase beta.The Yale journal of biology and medicine · 2013
    Review
  15. DNA polymerase β promoter mutations and transcriptional activity in esophageal squamous cell carcinoma.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2013
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Katherine A DoniganDepartment of Therapeutic Radiology, Yale School of Medicine, New Haven, CT 06520, United States.
Suzanne E Hile
Kristin A Eckert
Joann B Sweasy
Yale University · USCancer Research Foundation · USPennsylvania State University · US

Funding

PREDOCTORAL TRAINING PROGRAM IN GENETICST32GM007499 · NIGMS · YALE UNIVERSITY · PI CARLSON, JOHN R, REINKE, VALERIE J · 1985 to 2022
$13.9M
TUMOR SELECTIVE INACTIVATION OF THE REPAIR PROTEIN AGTP01CA129186 · NCI · YALE UNIVERSITY · PI GLAZER, PETER M · 2007 to 2012
$8.5M
NCI NIH HHS P01 CA129186NCI NIH HHS P01CA129186NIGMS NIH HHS T32 GM007499
6 · The paper itself

Abstract

Approximately 30% of human tumors sequenced to date harbor mutations in the POLB gene that are not present in matched normal tissue. Many mutations give rise to enzymes that contain non-synonymous single amino acid substitutions, several of which have been found to have aberrant activity or fidelity and transform cells when expressed. The DNA Polymerase β (Pol β) variant Asp160Asn (D160N) was first identified in a gastric tumor. Expression of D160N in cells induces cellular transformation as measured by hyperproliferation, focus formation, anchorage-independent growth and invasion. Here, we show that D160N is an active mutator polymerase that induces complex mutations. Our data support the interpretation that complex mutagenesis is the underlying mechanism of the observed cellular phenotypes, all of which are linked to tumorigenesis or tumor progression.

Indexed as

Amino Acid SubstitutionMutationAnimalsBase SequenceCell Line, TumorCell ProliferationCell Transformation, NeoplasticDNADNA-Binding ProteinsDNA Ligase ATPDNA LigasesDNA Polymerase betaGene Expression Regulation, NeoplasticGenomic InstabilityHumansMiceDNADNA-Binding ProteinsDNA Ligase ATPDNA ligase III alpha protein, XenopusDNA LigasesDNA Polymerase betaPoly-ADP-Ribose Binding ProteinsXenopus ProteinsX-ray Repair Cross Complementing Protein 1

Identifiers

PMID22341651
PMCPMC3624760
OpenAlexW2009437756

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.